Jennifer Barker, OTR/L | |
181 Main St, Norway, ME 04268-5664 | |
(207) 744-6160 | |
(207) 744-6529 |
Full Name | Jennifer Barker |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 181 Main St, Norway, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134983216 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | OT1328 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jennifer Barker, OTR/L 181 Main St, Norway, ME 04268-5664 Ph: (207) 744-6160 | Jennifer Barker, OTR/L 181 Main St, Norway, ME 04268-5664 Ph: (207) 744-6160 |
News Archive
A new study from the University of Eastern Finland shows that a relatively high intake of dietary cholesterol, or eating one egg every day, are not associated with an elevated risk of incident coronary heart disease. Furthermore, no association was found among those with the APOE4 phenotype, which affects cholesterol metabolism and is common among the Finnish population.
A new analysis published in IBIS examines whether bacteria, viruses, and other microorganisms that are present in wild vultures cause disease in the birds, and whether vultures play a role in spreading or preventing infectious diseases to humans and other animal species.
For patients with mesial temporal lobe epilepsy (MTLE) that can't be controlled by medications, a minimally invasive laser procedure performed under MRI guidance provides a safe and effective alternative to surgery, suggests a study in the June issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
Coinciding with the annual European Respiratory Society Congress, ERS 2012, SPIRIVA (tiotropium), the first once-daily long-acting inhaled anticholinergic maintenance treatment for patients with Chronic Obstructive Pulmonary Disease (COPD) will mark its 10th anniversary since launch.
Castrate-refractory prostate cancer, which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for the treatment of CRPC are lacking, and a number of factors must be considered when deciding between second-line hormonal therapy and chemotherapy.
› Verified 1 days ago
Leah Hanks, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 28 Winter St, Norway, ME 04268 Phone: 207-739-2021 Fax: 207-739-2188 | |
Corie Lucier, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 28 Winter St, Norway, ME 04268 Phone: 207-739-2021 | |
Miss Erin Victoria Jackson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 230 Main St, Norway, ME 04268 Phone: 508-341-0601 Fax: 207-743-7063 | |
Mr. Dominic Jean Roy, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 29 Marion Ave, Norway, ME 04268 Phone: 207-743-7075 | |
Mrs. Lyndsey Dawn Simpson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18 Grove St, Norway, ME 04268 Phone: 207-739-2242 | |
Amanda Lorentzen, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 28 Winter St, Norway, ME 04268 Phone: 207-739-2021 |